Further research has identified MMP13 as an enzyme capable of degrading the ECM, increasing the invasiveness of ESCC through interactions with CD44 and TWIST1, and it is recognized as a significant regulatory factor in the EMT process of ESCC. This evidence concerns the gene CD44 and esophageal squamous cell carcinoma.